Incidence of Foodborne Illnesses Reported by the Foodborne Diseases Active Surveillance Network (FoodNet)—1997

2000 ◽  
Vol 63 (6) ◽  
pp. 807-809 ◽  
Author(s):  
DAVID J. WALLACE ◽  
THOMAS VAN GILDER ◽  
SUE SHALLOW ◽  
TERRY FIORENTINO ◽  
SUZANNE D. SEGLER ◽  
...  
Keyword(s):  
United States ◽  
Food Safety ◽  
Active Surveillance ◽  
The United States ◽  
Incidence Rates ◽  
Foodborne Diseases ◽  
Surveillance Program ◽  
United States Department ◽  
Emerging Infections ◽  
Surveillance Network

In 1997, the Foodborne Diseases Active Surveillance Program (FoodNet) conducted active surveillance for culture-confirmed cases of Campylobacter, Escherichia coli O157, Listeria, Salmonella, Shigella, Vibrio, Yersinia, Cyclospora, and Cryptosporidium in five Emerging Infections Program sites. FoodNet is a collaborative effort of the Centers for Disease Control and Prevention's National Center for Infectious Diseases, the United States Department of Agriculture's Food Safety and Inspection Service, the Food and Drug Administration's Center for Food Safety and Applied Nutrition, and state health departments in California, Connecticut, Georgia, Minnesota, and Oregon. The population under active surveillance for food-borne infections was approximately 16.1 million persons or roughly 6% of the United States Population. Through weekly or monthly contact with all clinical laboratories in these sites, 8,576 total isolations were recorded: 2,205 cases of salmonellosis, 1,273 cases of shigellosis, 468 cases of cryptosporidiosis, 340 of E. coli O157:H7 infections, 139 of yersiniosis, 77 of listeriosis, 51 of Vibrio infections, and 49 of cyclosporiasis. Results from 1997 demonstrate that while there are regional and seasonal differences in reported incidence rates of certain bacterial and parasitic diseases, and that some pathogens showed a change in incidence from 1996, the overall incidence of illness caused by pathogens under surveillance was stable. More data over more years are needed to assess if observed variations in incidence reflect yearly fluctuations or true changes in the burden of foodborne illness.

scholarly journals Bacterial Enteric Infections Among Older Adults in the United States: Foodborne Diseases Active Surveillance Network, 1996–2012

2015 ◽  
Vol 12 (6) ◽  
pp. 492-499 ◽  
Author(s):  
Elaine Scallan ◽  
Stacy M. Crim ◽  
Arthur Runkle ◽  
Olga L. Henao ◽  
Barbara E. Mahon ◽  
...  
Keyword(s):  
United States ◽  
Older Adults ◽  
Active Surveillance ◽  
The United States ◽  
Foodborne Diseases ◽  
Surveillance Network ◽  
Enteric Infections

scholarly journals Travel-Associated Enteric Infections Diagnosed After Return to the United States, Foodborne Diseases Active Surveillance Network (FoodNet), 2004–2009

2012 ◽  
Vol 54 (suppl_5) ◽  
pp. S480-S487 ◽  
Author(s):  
Magdalena E. Kendall ◽  
Stacy Crim ◽  
Kathleen Fullerton ◽  
Pauline V. Han ◽  
Alicia B. Cronquist ◽  
...  
Keyword(s):  
United States ◽  
Active Surveillance ◽  
The United States ◽  
Foodborne Diseases ◽  
Surveillance Network ◽  
Enteric Infections

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less Than 3 Years of Age From the United States New Vaccine Surveillance Network: A Multisite Active Surveillance Program, 2006–2016

2020 ◽  
Author(s):  
Mary Allen Staat ◽  
Daniel C Payne ◽  
Natasha Halasa ◽  
Geoffrey A Weinberg ◽  
Stephanie Donauer ◽  
...  
Keyword(s):  
United States ◽  
Disease Burden ◽  
The United States ◽  
Population Based ◽  
Surveillance Program ◽  
Surveillance Network ◽  
Rotavirus Vaccination ◽  
Ed Visits ◽  
The Impact ◽  
Vaccine Surveillance

Abstract Background Since 2006, the New Vaccine Surveillance Network has conducted active, population-based surveillance for acute gastroenteritis (AGE) hospitalizations and emergency department (ED) visits in 3 United States counties. Trends in the epidemiology and disease burden of rotavirus hospitalizations and ED visits were examined from 2006 to 2016. Methods Children < 3 years of age hospitalized or visiting the ED with AGE were enrolled from January 2006 through June 2016. Bulk stool specimens were collected and tested for rotavirus. Rotavirus-associated hospitalization and ED visit rates were calculated annually with 2006–2007 defined as the prevaccine period and 2008–2016 as the postvaccine period. Rotavirus genotype trends were compared over time. Results Over 11 seasons, 6954 children with AGE were enrolled and submitted a stool specimen (2187 hospitalized and 4767 in the ED). Comparing pre- and postvaccine periods, the proportion of children with rotavirus dramatically declined for hospitalization (49% vs 10%) and ED visits (49% vs 8%). In the postvaccine era, a biennial pattern of rotavirus rates was observed, with a trend toward an older median age. G1P[8] (63%) was the predominant genotype in the prevaccine period with a significantly lower proportion (7%) in the postvaccine period (P < .001). G2P[4] remained stable (8% to 14%) in both periods, whereas G3P[8] and G12P[8] increased in proportion from pre- to postvaccine periods (1% to 25% and 17% to 40%), respectively. Conclusions The epidemiology and disease burden of rotavirus has been altered by rotavirus vaccination with a biennial disease pattern, sustained low rates of rotavirus in children < 3 years of age, and a shift in the residual genotypes from G1P[8] to other genotypes.

Economic Cost of Illness Due to Escherichia coli O157 Infections in the United States

2005 ◽  
Vol 68 (12) ◽  
pp. 2623-2630 ◽  
Author(s):  
PAUL D. FRENZEN ◽  
ALISON DRAKE ◽  
FREDERICK J. ANGULO ◽  
Keyword(s):  
United States ◽  
Escherichia Coli ◽  
Medical Care ◽  
Cost Of Illness ◽  
Severity Of Illness ◽  
Economic Cost ◽  
The United States ◽  
Escherichia Coli O157 ◽  
Emerging Infections ◽  
Surveillance Network

The Centers for Disease Control and Prevention (CDC) has estimated that Shiga toxin–producing Escherichia coli O157 (O157 STEC) infections cause 73,000 illnesses annually in the United States, resulting in more than 2,000 hospitalizations and 60 deaths. In this study, the economic cost of illness due to O157 STEC infections transmitted by food or other means was estimated based on the CDC estimate of annual cases and newly available data from the Foodborne Diseases Active Surveillance Network (FoodNet) of the CDC Emerging Infections Program. The annual cost of illness due to O157 STEC was $405 million (in 2003 dollars), including $370 million for premature deaths, $30 million for medical care, and $5 million in lost productivity. The average cost per case varied greatly by severity of illness, ranging from $26 for an individual who did not obtain medical care to $6.2 million for a patient who died from hemolytic uremic syndrome. The high cost of illness due to O157 STEC infections suggests that additional efforts to control this pathogen might be warranted.

Sign in / Sign up

Export Citation Format

Share Document